Mamaearth's makeover is proving costly. Can it overcome its challenges?

Mamaearth, one of India's pioneering digital-first beauty and personal care brands, quickly became a household name with its toxin-free, eco-friendly products. Propelled by a strong online presence, aggressive marketing and a focus on conscious consumerism, the brand enjoyed rapid success. However, a 45 per cent decline in its stock price over the past two months has placed its business practices and strategy under the microscope.

Let's evaluate the company's current challenges, the broader issues at play and the potential road ahead.

Financial struggles: The numbers tell the story

In Q2 FY25, the company reported a 6.9 per cent YoY revenue decline. Even after adjusting for inventory corrections, the revenue growth was a modest 5.7 per cent YoY. What's more concerning is the operating loss of Rs 41 crore, compared to an operating profit of Rs 34 crore in the same period the previous year.

The company's cash flow from operations also turned negative in H1 FY25, a significant shift from the previous year, highlighting mounting financial strain.

The decline can largely be attributed to Project Neev, an initiative aimed at transitioning from super-stockists to direct distributors in the top 50 cities. While this strategy may bring long-term efficiencies, it has caused significant short-term disruptions. The one-time inventory corrections, worth Rs 64 crore, negatively impacted both revenue and profitability.

Project Neev: Strategic intent vs operational execution

Project Neev will bring about a structural overhaul of Mamaearth's distribution strategy. Key changes include:

• Removing the super-stockist layer in major cities.
  
• Implementing a direct distribution model for better control and transparency.
  
• Upgrading supply chain capabilities with real-time inventory visibility.

While the initiative is expected to strengthen the company's offline presence over time, the implementation has revealed execution gaps. Management estimates two to three quarters to stabilise operations, leaving investors wary of further disruptions.

Adding to this, past concerns of overstocking distributors during the IPO period suggest that inventory management has been an ongoing challenge for the company. Such issues amplify the need for proper planning and execution to regain investor trust.

Beyond short-term struggles: A bigger issue looms

During the Q2 earnings call, management acknowledged a critical reality: what worked to grow Mamaearth to Rs 1,000 crore in revenue will not work to take it forward.

While the company's newer brands, such as The Derma Co. and Aqualogica, are growing at a faster clip (30 per cent YoY growth), they come from a smaller base. Moreover, these brands operate in similar product lines as Mamaearth, suggesting the same growth challenges may arise as they scale.

This leaves the company to compete with legacy FMCG giants like Hindustan Unilever in the offline space, a battleground that demands deep pockets, efficient operations and strong brand equity.

The road ahead

The fall in share price has sharpened after the Q2 FY25 results, but does it make an investment opportunity? Here are some factors to consider:

• Business model shift: The company is moving toward an offline distribution model, aligning more with traditional FMCG companies. This transition is expensive and operationally challenging.
  
• High marketing reliance: The company's marketing spend accounts for 40 per cent of its revenue (as of Q2 FY25), far higher than the 5 per cent average for legacy FMCG players. This raises concerns about sustainability and profitability.

For investors, the company's journey underscores the importance of scrutinising growth narratives and being patient through transitions. Mamaearth might have potential, but its ability to deliver on strategic initiatives will determine whether it can eventually regain its footing.

You might also like: 9 five-star stocks that turned attractive the past week